Rapilif (Rapaflo)4 Mg – 100 tablet

Name: Rapilif (Rapaflo)4 Mg – 100 tablet
SKU: 75b4f6aa7912
Availability: InStock

$108.97

Each Rapilif contains 4 mg Silodosin 100 tablets. Used to treat the signs and symptoms of benign prostatic hyperplasia (prostate enlargement).

ATC Classification: G04CA04
Active Ingrediant: Silodosin
Generic Name: Rapilif
Manufacturer: IPCA Lab Ltd
Strength: 4 Mg
Dosage Type: Tablet
Packaging Type: Foil in Box
Contains: 100 Tabs

Important update for customers in the USA:

Most of the World has stopped all packages mailing to the USA due to De Minimus Exemption.

WE ARE SHIPPING TO THE USA The only or best option right now is trans shipment to the USA, we are holding India post and express mail shipments until India sets up a taxation / tariff collection system on our side which they say can take 1 month or longer.
We ship normally to the UK, AUS, Japan, and most others. The situation only involves the USA.
For people who have placed an order for express mail we will ship this out once India mail is open or you can contact us to make arrangements to ship through Trans Shipping and pay the tariff and shipping costs this way.
We are very sorry for this, the USA policy shift came fast, without rules or regulations, and not understanding of what other countries should do.
As things develop we will adjust our shipping prices and operations to best service you.

Thanks for your patience.

Ipca Lab

Medication Safety Issues

Sound-alike/look-alike issues:

Rapaflo may be confused with Rapamune

Silodosin may be confused with sildenafil, sirolimus

Storage/Stability

Store at room temperature of 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). Protect from light. Protect from moisture.

Adverse Reactions

>10%: Genitourinary: Retrograde ejaculation (28%)

1% to 10%:

Cardiovascular: Orthostatic hypotension (3%; increased in elderly ≥65 years up to 5%)

Central nervous system: Dizziness (3%), headache (2%), insomnia (1% to 2%)

Gastrointestinal: Diarrhea (3%), abdominal pain (1% to 2%)

Genitourinary: Prostate specific antigen increased (1% to 2%)

Neuromuscular & skeletal: Weakness (1% to 2%)

Respiratory: Nasal congestion (2%), rhinorrhea (1% to 2%), sinusitis (1% to 2%)

<1%, postmarketing, and/or case reports: Hepatic insufficiency, hypersensitivity reaction, increased serum transaminases, intraoperative floppy iris syndrome, jaundice, pharyngeal edema, priapism, pruritus, purpura, skin rash (including toxic), swollen tongue, syncope, urticaria

Additional information

Active Ingrediant	Rapaflo
Generic Name	Rapilif
Alternate Names	Congdosin, Curepass, Flopadex, Lisoflak, Rapasin, Silodyx, Siloflo, Silosin, Silotrif, Thrupas, Truwin, Unipass, Urief, Urorec
Strength	4 mg
Dosage Type	Tablet
Packaging Type	Foil in Box